Skip to main content
Literatur
1.
Zurück zum Zitat Kostos L, Burbury K, Srivastava G, Prince HM (2015) Gastrointestinal bleeding in a chronic myeloid leukaemia patient precipitated by dasatinib-induced platelet dysfunction: case report. Platelets 26(8):809–811CrossRefPubMed Kostos L, Burbury K, Srivastava G, Prince HM (2015) Gastrointestinal bleeding in a chronic myeloid leukaemia patient precipitated by dasatinib-induced platelet dysfunction: case report. Platelets 26(8):809–811CrossRefPubMed
2.
Zurück zum Zitat Mustafa Ali MK, Sabha MM, Al-Rabi KH (2015) Spontaneous subdural hematoma in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia with normal platelet count after dasatinib treatment. Platelets 26(5):491–494CrossRefPubMed Mustafa Ali MK, Sabha MM, Al-Rabi KH (2015) Spontaneous subdural hematoma in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia with normal platelet count after dasatinib treatment. Platelets 26(5):491–494CrossRefPubMed
3.
Zurück zum Zitat Choi JL, Li S, Han JY (2014) Platelet function tests: a review of progresses in clinical application. BioMed research international. 2014:456569PubMedPubMedCentral Choi JL, Li S, Han JY (2014) Platelet function tests: a review of progresses in clinical application. BioMed research international. 2014:456569PubMedPubMedCentral
4.
Zurück zum Zitat Gora-Tybor J, Medras E, Calbecka M, Kolkowska-Lesniak A, Ponikowska-Szyba E, Robak T et al (2015) Real-life comparison of severe vascular events and other non-hematological complications in patients with chronic myeloid leukemia undergoing second-line nilotinib or dasatinib treatment. Leuk Lymphoma 56(8):2309–2314CrossRefPubMed Gora-Tybor J, Medras E, Calbecka M, Kolkowska-Lesniak A, Ponikowska-Szyba E, Robak T et al (2015) Real-life comparison of severe vascular events and other non-hematological complications in patients with chronic myeloid leukemia undergoing second-line nilotinib or dasatinib treatment. Leuk Lymphoma 56(8):2309–2314CrossRefPubMed
5.
Zurück zum Zitat Quintas-Cardama A, Han X, Kantarjian H, Cortes J (2009) Tyrosine kinase inhibitor-induced platelet dysfunction in patients with chronic myeloid leukemia. Blood 114(2):261–263CrossRefPubMedPubMedCentral Quintas-Cardama A, Han X, Kantarjian H, Cortes J (2009) Tyrosine kinase inhibitor-induced platelet dysfunction in patients with chronic myeloid leukemia. Blood 114(2):261–263CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Haouala A, Widmer N, Duchosal MA, Montemurro M, Buclin T, Decosterd LA (2011) Drug interactions with the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib. Blood 117(8):e75–e87CrossRefPubMed Haouala A, Widmer N, Duchosal MA, Montemurro M, Buclin T, Decosterd LA (2011) Drug interactions with the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib. Blood 117(8):e75–e87CrossRefPubMed
7.
Zurück zum Zitat Bachmair EM, Ostertag LM, Zhang X, de Roos B (2014) Dietary manipulation of platelet function. Pharmacol Ther 144(2):97–113CrossRefPubMed Bachmair EM, Ostertag LM, Zhang X, de Roos B (2014) Dietary manipulation of platelet function. Pharmacol Ther 144(2):97–113CrossRefPubMed
8.
Zurück zum Zitat Abdolahi A, Georas SN, Brenna JT, Cai X, Thevenet-Morrison K, Phipps RP et al (2014) The effects of aspirin and fish oil consumption on lysophosphatidylcholines and lysophosphatidic acids and their correlates with platelet aggregation in adults with diabetes mellitus. Prostaglandins Leukot Essent Fatty Acids 90(2–3):61–68CrossRefPubMed Abdolahi A, Georas SN, Brenna JT, Cai X, Thevenet-Morrison K, Phipps RP et al (2014) The effects of aspirin and fish oil consumption on lysophosphatidylcholines and lysophosphatidic acids and their correlates with platelet aggregation in adults with diabetes mellitus. Prostaglandins Leukot Essent Fatty Acids 90(2–3):61–68CrossRefPubMed
9.
Zurück zum Zitat Takagi Y, Aota Y, Gotoh A, Sakurai M (2010) Effect of low-dose dasatinib in an elderly patient with chronic myelogenous leukemia (CML). Cancer Chemother 37(11):2213–2215 Takagi Y, Aota Y, Gotoh A, Sakurai M (2010) Effect of low-dose dasatinib in an elderly patient with chronic myelogenous leukemia (CML). Cancer Chemother 37(11):2213–2215
10.
Zurück zum Zitat Saito M, Izumiyama K, Mori A, Irie T, Tanaka M, Morioka M et al (2014) Intestinal bleeding in patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors. [Rinsho ketsueki]. Jpn J Clin Hematol 55(1):130–132 Saito M, Izumiyama K, Mori A, Irie T, Tanaka M, Morioka M et al (2014) Intestinal bleeding in patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors. [Rinsho ketsueki]. Jpn J Clin Hematol 55(1):130–132
Metadaten
Titel
Dasatinib and Dysfunction of Platelets
verfasst von
Kamal Kant Sahu
Uday Yanamandra
Vikrant Bhar
Deba Prasad Dhibar
Subhash Chander Varma
Pankaj Malhotra
Publikationsdatum
23.02.2016
Verlag
Springer India
Erschienen in
Indian Journal of Hematology and Blood Transfusion / Ausgabe Sonderheft 1/2016
Print ISSN: 0971-4502
Elektronische ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-016-0659-x

Weitere Artikel der Sonderheft 1/2016

Indian Journal of Hematology and Blood Transfusion 1/2016 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.